FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $344,000 | -38.5% | 4,175 | -32.1% | 0.00% | 0.0% |
| Q4 2020 | $559,000 | +107.8% | 6,146 | -8.7% | 0.00% | 0.0% |
| Q3 2020 | $269,000 | +1.1% | 6,734 | -14.9% | 0.00% | 0.0% |
| Q2 2020 | $266,000 | +88.7% | 7,917 | -27.9% | 0.00% | 0.0% |
| Q4 2018 | $141,000 | +27.0% | 10,977 | -60.8% | 0.00% | 0.0% |
| Q3 2017 | $111,000 | +22.0% | 28,000 | 0.0% | 0.00% | – |
| Q2 2017 | $91,000 | -13.3% | 28,000 | +21.7% | 0.00% | -100.0% |
| Q1 2017 | $105,000 | +144.2% | 23,000 | +35.3% | 0.00% | – |
| Q4 2016 | $43,000 | -18.9% | 17,000 | 0.0% | 0.00% | – |
| Q3 2016 | $53,000 | +82.8% | 17,000 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | -6.5% | 17,000 | 0.0% | 0.00% | – |
| Q1 2016 | $31,000 | +29.2% | 17,000 | +142.9% | 0.00% | – |
| Q4 2015 | $24,000 | -11.1% | 7,000 | +40.0% | 0.00% | – |
| Q3 2015 | $27,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |